Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,222,588
+$1,561,087 QoQ
Shares Held
32,676
+6.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,023
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$100,656
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. ABBV ranks #3 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,656 | 400 | Call | Sole | 2026-07-29 | |
| 2026-06-30 | $8,222,588 | 32,676 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,661,501 | 30,629 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $6,755,306 | 29,565 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,541,005 | 28,250 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $5,146,500 | 27,726 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,521,061 | 26,351 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $4,493,499 | 25,287 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,895,134 | 24,788 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,113,049 | 23,980 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,194,673 | 23,035 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,479,541 | 22,453 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $3,253,681 | 21,828 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $2,866,111 | 21,273 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,228,517 | 20,258 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,595,176 | 22,246 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,732,515 | 20,360 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,690,714 | 17,568 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,455,318 | 15,146 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,828,983 | 13,508 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,232,199 | 11,423 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,238,814 | 10,998 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,063,153 | 9,824 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $932,955 | 8,707 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $657,538 | 7,507 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $693,543 | 7,064 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $454,549 | 5,966 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||